文献速递外周动脉疾病

间歇性跛行运动处方系统综述:疼痛程度是否重要?

A Systematic Review of Exercise Prescription in Patients with Intermittent Claudication: Does Pain Matter?
PubMed 文献 · Ann Vasc Surg · 2021-08-28

该系统综述检索CENTRAL、MEDLINE、Embase和CINAHL至2020年10月,纳入直接比较至少两种跛行疼痛强度运动方案的随机对照试验,最终仅纳入2项研究。中等疼痛监督运动组最大步行距离改善100-128%,无痛组改善77-90%,两项研究均未发现两组步行表现改善存在显著差异,但均未与最大疼痛组比较。

要点

  • 中等疼痛与无痛监督运动均改善间歇性跛行患者最大步行距离。
  • 两项纳入研究均未发现中等疼痛与无痛组步行表现改善有显著差异。
  • 尚无足够证据确定最佳跛行疼痛水平,需充分把握度的随机对照试验。

核心结论

  • 监督运动方案对间歇性跛行患者有效,但最佳疼痛水平尚无共识。
  • 中等疼痛与无痛监督运动组步行表现改善无显著差异,但未与最大疼痛组比较。

研究设计与样本

  • 系统综述,检索CENTRAL、MEDLINE、Embase和CINAHL至2020年10月。
  • 纳入直接比较至少两种跛行疼痛强度运动方案的随机对照试验,最终纳入2项研究。

主要发现

  • 中等疼痛监督运动组最大步行距离改善100-128%。
  • 无痛监督运动组最大步行距离改善77-90%。
  • 两项研究均未发现中等疼痛与无痛监督运动组步行表现改善有显著差异。

关键数值与推荐

  • 结局指标包括步行表现、依从性、生活质量和血管功能。

临床怎么用

  • 监督运动方案可用于间歇性跛行患者,疼痛水平选择需个体化。
  • 无痛或中等疼痛运动可能作为可耐受的替代方案,但需更多证据支持。

局限性

  • 仅纳入2项研究,证据有限。
  • 未比较最大疼痛监督运动组与中等疼痛或无痛组。
  • 需充分把握度的随机对照试验比较无痛、中等疼痛和最大疼痛监督运动方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines for intermittent claudication advocate exercise at moderate to maximal claudication pain. However, adherence rates to supervised exercise programmes (SEP) remain poor and claudication pain is a contributing factor. Limited evidence suggests that moderate or pain-free exercise may be just as beneficial and may be better tolerated. However, it remains unclear what 'level' of claudication pain is optimal for improving functional outcomes. We therefore conducted a systematic review to synthesise the evidence for exercise prescribed at different levels of claudication pain. METHODS: The CENTRAL, MEDLINE, Embase and CINAHL databases were searched up to October 2020. Randomized controlled trials (RCTs) that directly compared at least 2 different intensities of claudication pain were included. Outcome measures included walking performance, adherence, quality of life and vascular function. RESULTS: Of 1,543 search results, 2 studies were included. Maximal walking distance improved by 100-128% in the moderate-pain SEP groups, and by 77-90% in the pain-free SEP groups. Importantly, there were no significant differences between the moderate-pain and pain-free SEP groups in either study for improvements in walking performance, though comparison to a maximal-pain SEP group was not made. CONCLUSIONS: The efficacy of SEPs for patients with intermittent claudication is irrefutable, though there is no consensus on the optimal level of pain. Therefore, adequately powered RCTs are required to compare the effect of pain-free SEPs, moderate-pain SEPs and maximal-pain SEPs on functional outcomes. (PROSPERO ID: CRD42020213684).

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Seed SA, Harwood AE, Sinclair J, et al. A Systematic Review of Exercise Prescription in Patients with Intermittent Claudication: Does Pain Matter? Ann Vasc Surg. 2021. PMID: 34464728. doi:10.1016/j.avsg.2021.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。